MorningSignal
Research Platform
2026-04-11 21:47
Prepared: April 7, 2026 | Morning Run | Analyst: EarningsBrief Automated System Coverage: US-listed stocks >$2B market cap | BMO April 7 + AMC April 6 catch-up
One significant large-cap company reported before the market open this morning: McCormick & Company (MKC), which delivered a genuine Q1 FY2026 beat on both EPS and revenue — but the stock remains under pressure from the dilutive $44.8 billion Unilever Foods merger announced March 31. No large-cap ($2B+) companies reported after market close on April 6, so there are no catch-up items from last evening's 8 PM run. The story this morning is MKC: strong fundamental execution buried under a transformational deal that is reshaping investor perception of the company. Tonight brings Levi Strauss (LEVI) AMC, and tomorrow opens the real earnings season with Delta Air Lines (DAL) and RPM International (RPM) BMO, followed by Constellation Brands (STZ) AMC.
Macro backdrop: Q1 2026 earnings season kicks off against a volatile market — the S&P 500 is down ~5–9% from highs amid an oil shock (crude >$100/barrel), Trump's Iran ceasefire deadline today, and elevated bearish sentiment (AAII bears at 51.4%). Consensus expects 13.2% S&P 500 EPS growth for Q1 2026 — this week's prints are the first real data points.
MKC — Hold / No New Position until Unilever merger clarity. The underlying Q1 beat is real (organic pricing holding, de Mexico accretion performing), but the deal structure (MKC shareholders get only 35% of the combined entity) creates profound near-term uncertainty. The stock's YTD decline of ~25% already prices in significant pain. Buy-the-dip only on evidence that regulatory approval path is smooth and synergy targets ($600M) are achievable. Conviction: Medium.
DAL (reporting tomorrow BMO) — Tactical Long bias. Delta raised Q1 revenue guidance to $15–$15.3B vs. the original $14.82B Street estimate — a meaningful and rare pre-announcement upward revision. In a volatile macro environment, Delta's refinery hedge and premium cabin demand diversification provide relative defensibility. Risk: oil at $100+ is still a structural headwind. Conviction: Medium-High.
LEVI (reporting tonight AMC) — Watch closely. Dockers divestiture removes a drag, DTC at 50% of revenue is a structural positive, and gross margin has held at ~61%. However, tariff exposure (China 30%, ROW 20%) adds 6.6% to import costs. A revenue beat plus maintained gross margin guidance would be the bull case. EPS estimate of $0.37 has a 27% historical beat rate. Do not front-run.
Fiscal Q1 2026 (quarter ended February 28, 2026) | Reported: April 7, 2026 BMO
| Metric | Actual | Consensus | Beat/Miss | YoY |
|---|---|---|---|---|
| Adjusted EPS | $0.66 | $0.61 | +8.2% beat | n/a |
| GAAP EPS | $3.77 | n/a | — | Inflated by $866.8M de Mexico remeasurement gain |
| Net Revenue | $1,873.9M | $1,790M | +4.7% beat | +16.7% |
| Consumer Segment Revenue | $1,145.0M | n/a | — | +24.5% reported; +1.8% organic |
| Flavor Solutions Segment Revenue | $729M | n/a | — | +6.2% reported; +0.5% organic |
| Adjusted Gross Margin | 38.6% | ~37.5% est. | +110 bps beat | +100 bps YoY |
| Adjusted Operating Income | $267.6M | n/a | — | +18.8% YoY |
| Adj. Operating Margin | 14.3% | ~14.0% est. | +30 bps | +30 bps YoY |
Quality assessment: The headline beat is partially artificial — the 16.7% revenue growth is dominated by McCormick de Mexico consolidation (approximately 12.4 percentage points) and a 3.1% favorable currency tailwind, leaving organic growth of just 1.2% — below trend and driven almost entirely by pricing (+2.1%) while volume declined -0.9%. This is not a clean organic beat; it is an acquisition/FX-inflated headline with modest underlying demand.
McCormick reaffirmed fiscal year 2026 guidance: - Net sales growth: +13% to +17% (with ~11–13pp from McCormick de Mexico) - Organic sales growth: +1% to +3% (effectively unchanged) - No explicit EPS guidance update was provided on a standalone basis (the focus pivoted entirely to the Unilever transaction framework)
The combined entity post-merger targets by year three: - Annual revenues: ~$20 billion - Operating margins: 23%–25% - Organic sales growth: 3%–5% - Cost synergies: $600M run-rate
Assessment: Guidance is effectively sandbagged on organic growth (1–3% is conservative), but the absence of clear standalone EPS guidance for the back half of 2026 is a problem. Analysts are flying partially blind on MKC's earnings power through the merger close expected in mid-2027.
Based on available call summaries and analyst Q&A reporting:
Management tone: Distinctly bifurcated. On Q1 underlying results, CEO Brendan Foley was measured and confident — "strong first quarter performance" — with specific callouts on CCI program savings and de Mexico integration. On the Unilever merger, tone shifted to aspirational and strategic, with considerable prepared language about "the global flavor powerhouse" and "$20 billion in revenues." This is a deal-focused call more than an earnings call.
Key prepared remarks phrases: - "Leverage external advisors and dedicated leadership, with integration playbooks tailored by region" — Foley, on integration risk - "Most Unilever Foods operations already run independently, minimizing disruption" — detail on TSA (Transitional Service Agreements) scope - "Sustainable organic sales growth of 3% to 5% by year three, supported by a $100 million incremental reinvestment in brand marketing and innovation" — combined entity target - "Operating margins will expand to a range of 23% to 25% through procurement scale, supply chain optimization, and SG&A leverage" — financial framework post-merger
What management DID NOT say: There was no direct commentary on whether FY2026 standalone EPS guidance would be updated. No specific mention of tariff exposure on the existing McCormick business. No quantification of the cash financing cost (McCormick will pay $15.7B in cash — at current rates, this is significant incremental interest expense).
Five key analyst questions dominated:
Andrew Lazar (Barclays) — Integration Risk: Pushed hard on execution risk of a deal this size. Foley deflected with process language ("external advisors," "playbooks"), but notably did not provide a specific integration milestone timeline. Tone: Scripted, somewhat evasive on specifics.
Stephen Powers (Deutsche Bank) — TSA Scope & Cost: Sought quantification of transitional service agreements. Management said most Unilever Foods businesses operate independently — interpreted as minimizing TSA complexity. No specific TSA cost or duration was disclosed — a notable gap.
Thomas Palmer (JPMorgan) — Sales Growth Sources: Pressed management on whether the 3–5% combined organic target relies on industry recovery or self-help. Foley framed it as "primarily self-help" — a responsible and credible answer that analysts appeared to accept.
Alexia Howard (Bernstein) — Synergy Timeline & EPS Accretion: Sought year-by-year accretion path. CFO Marcos Gabriel confirmed "meaningfully accretive" with $600M synergies, but declined to provide specific accretion timing. No year 1/year 2 EPS bridge given — investors are operating without a clear model.
Peter Galbo (Bank of America) — Regional Opportunity (Latin America, Asia): Both Foley and Unilever CEO Fernando Fernández (notable that the Unilever CEO was on the call) engaged positively, citing Hellmann's in Latin America and McCormick in Asia as growth levers. The cross-selling narrative was the most concrete positive in the call.
Bottom line on Q&A: Analysts were polite but clearly pressing for financial specificity that management was not prepared to give. The call reinforced the deal's strategic logic but left investors without the modeling scaffolding needed to assess near-term earnings power.
| Timeframe | Price Action |
|---|---|
| Premarket (pre-open April 7) | -7.15% to ~$49.88 |
| Intraday April 7 | Range $48.58–$51.09 |
| Current (approx. session) | ~$50.80, +3.99% from prior close of ~$48.85 |
| YTD Performance | -25.4% |
| 52-week range | $47.52–$78.16 |
| JPMorgan current PT | $64 (recently lowered) |
Assessment: The initial premarket panic (-7%) reversed sharply intraday to +4%, suggesting the sell-off was mechanical (algorithm-driven overreaction to the merger overhang) rather than fundamental. Investors reading the actual Q1 numbers recognized a genuine beat with margin expansion, stabilized the stock, and began pricing in the deal's optionality.
The market reaction is partially rational but still confused. The merger, not the Q1 print, is driving valuation. The stock's true test will come when: (a) The merger proxy is filed with specific financial modeling (b) Regulatory approval trajectory becomes clearer (c) Management provides a standalone FY2026 EPS path through deal close
Is the market overreacting? Yes to the downside intraday. The underlying MKC business generated $267.6M in adjusted operating income in Q1 alone — this is a cash-generative, margin-expanding business. But is the YTD -25% overreaction? Probably not — the Unilever deal raises legitimate questions about long-term standalone EPS trajectory that will take quarters to resolve.
Positioning call: HOLD. Do not chase the intraday reversal.
McCormick's core business is performing — organic pricing is holding, margins are expanding, and the de Mexico acquisition is integrating as expected. None of that is in question. The question is what you're buying: a $12B spice company growing organically at 1.2%, or a future 35% stake in a $65B flavor conglomerate with Hellmann's and Knorr.
The latter is potentially transformational upside — $600M in synergies on a $20B revenue base with 23-25% operating margins is a compelling long-term picture. But the path from here to mid-2027 close is filled with: - $15.7B in cash financing costs (est. ~$800M+ incremental annual interest at current rates) - Regulatory approval risk in the US and EU - Management bandwidth distraction - Shareholder dilution (McCormick shareholders go from 100% to 35%) - No EPS bridge provided
Conviction: Medium — Cautious Hold Key risk to thesis: Regulatory rejection or deal re-pricing that forces MKC to absorb deal costs without the Unilever upside Catalyst timeline: Merger proxy filing (est. Q3 2026); regulatory milestones (H1 2027); any standalone FY2026 EPS guidance update One sentence for the PM: McCormick beat the quarter cleanly but the call was a deal roadshow, not an earnings call — hold here and wait for the proxy filing before adding.
Theme 1 — Transformational M&A Overrides Earnings Signal: McCormick's quarter is a perfect case study in how corporate activity can completely overshadow fundamental performance. A clean 8%+ EPS beat with margin expansion was irrelevant to the stock because the merger announcement fundamentally altered the investment thesis. PM should watch for similar dynamics at other companies this season (STZ beer portfolio rationalization, DAL potential fleet deals).
Theme 2 — Organic Volume Pressure vs. Pricing: McCormick's organic revenue growth of 1.2% was 100% pricing (+2.1%) against a volume decline (-0.9%). This is the critical debate heading into Q1 earnings season broadly: can companies hold price while volume recovers, or is elasticity starting to bite? Consumer staples showing volume compression even as price holds is a macro warning signal.
Theme 3 — "Oil Shock of 2026" as the Dominant Macro Variable: With crude over $100/barrel and Trump's Iran ceasefire deadline today (Tuesday evening), the market is in a risk-off posture that will color every earnings reaction this week. Companies like Delta (fuel cost exposure) and McCormick (energy-intensive manufacturing and logistics) face structural cost headwinds that weren't present in Q4 2025.
No catch-up items from April 6, 2026 AMC. No large-cap US-listed companies (>$2B market cap) reported quarterly earnings after the close on April 6, 2026. The 13 earnings reports scheduled for April 6 were predominantly small/micro-cap names outside our coverage filter.
Note: AMC Entertainment (ticker: AMC) released an attendance announcement on April 6 (+14% stock move on record Easter weekend / 6M+ guests), but this was not a quarterly earnings release.
Reports: After Close, April 7 | Call: 5:00 PM ET (2:00 PM PT)
| Key Metric | Street Estimate | Context |
|---|---|---|
| EPS (adj.) | $0.37 | -2.6% YoY; historically beats by 27% |
| Revenue | $1.65B | +3.2% YoY; consensus range $1.62B–$1.68B |
| Gross Margin | ~61% | Key watch vs. tariff headwinds |
| DTC Mix | ~50% of revenue | Structural shift in progress |
What to watch: - Tariff guidance: How is LEVI managing China 30% / ROW 20% tariff exposure? Do they raise prices or absorb? Any supply chain re-routing commentary is actionable. - Dockers divestiture impact: Finalized in early March — first clean quarter without Dockers drag. Does management frame improved margin profile explicitly? - DTC growth rate: If DTC grows >10% while wholesale stabilizes, the margin story accelerates. If DTC is decelerating, alarm bells. - Gross margin guidance: Any compression below 60% on tariff pass-through would be negative. Holding 61%+ in this environment would be a beat signal. - Full-year guidance: The company has average trailing 4-quarter EPS surprise of 26.9% — the bar is beatable. Watch for whether they guide conservatively (tariff sandbagging) or maintain original FY2026 outlook.
Risk: Elevated tariff costs (6.6% apparel cost increase) + consumer spending softness in discretionary (jeans are not recession-proof) = margin compression + potential volume weakness. The DTC pivot is not complete — they still have wholesale dependency.
EPS est. $0.64 (+39% YoY) | Rev est. $14.82B raised to $15.0–$15.3B by management - Delta pre-announced Q1 revenue upward revision (5–7% → high-single-digit growth = $15–$15.3B) - Watch: premium/international revenue mix, fuel cost management, forward Q2 yield commentary - Oil at $100+ is the single biggest risk to DAL's forward guidance
EPS est. $0.35 (flat YoY) | Rev est. $1.55B (+4.7% YoY) - Last quarter missed badly (-14.9% EPS, -1.0% revenue vs. estimates) - Watch: Has the construction/maintenance demand environment improved since last quarter's miss? Any commentary on commercial vs. residential end markets - Negative average 4-quarter EPS surprise of -9.9% — manage expectations carefully
EPS est. $1.71 (+35% YoY) | Rev est. $1.87B (-13% YoY) - UBS PT $176 (Buy) with below-consensus $1.59 EPS estimate - Watch: Beer portfolio (Modelo/Corona) demand under trade tension with Mexico; wine/spirits divestiture progress - Options traders pricing ±5.6% move vs. 2.89% historical average — elevated uncertainty
| Indicator | Status |
|---|---|
| S&P 500 YTD | Volatile; off ~5–9% from highs |
| Q1 2026 EPS growth (consensus) | +13.2% YoY |
| Full-year 2026 EPS growth (FactSet) | +17% |
| AAII Bearish Sentiment | 51.4% — historically bullish contrarian signal |
| Forward Equity Risk Premium | ~0.02% — near record lows, valuations stretched |
| Oil Price | >$100/barrel (Oil Shock of 2026) |
| Iran Ceasefire Deadline | Today (Tuesday evening) — geopolitical risk elevated |
Big-picture context for PM: The market is entering Q1 earnings season in a defensive crouch. The fundamental setup (13%+ EPS growth expected) is strong, but the macro backdrop (oil shock, geopolitical risk, stretched valuations) means beats need to be clean and guidance needs to be raised — in-line results are likely to be punished. McCormick's experience today (clean beat, stock initially sells off 7% before recovering) illustrates this dynamic. Coming into this earnings season with excess cash and a willingness to buy clean-beat pullbacks (particularly in oil-insulated quality companies) is the right posture.
Sources: Investing.com McCormick earnings transcript, FinancialContent StockStory MKC Q1 analysis (April 7, 2026), Yahoo Finance/StockTitan MKC earnings summaries, ir.mccormick.com press release, CNBC/Bloomberg McCormick-Unilever merger coverage (March 31, 2026), Earnings Whispers calendar data, FactSet Q1 2026 earnings preview, Alphastreet DAL earnings preview, Barchart/Zacks RPM/STZ estimates.
EarningsBrief | Morning Edition | April 7, 2026 | Automated Run